Pain and function improved with Hyalgan in treatment of knee OA in the Asian population .
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2013;1(18):20. 2011 ;():.
200 patients were randomized to investigate the efficacy of sodium hyaluronate in the treatment of knee osteoarthritis in the Asian population. Patients were allocated to receive 5 weekly intra-articular (i.a.) injections of Hyalgan or saline placebo, and were followed-up for 20 weeks afterward. The results indicated that patients who were treated with i.a. sodium hyaluronate experienced significantly improved pain and function compared to those treated with placebo saline solution.
Was the allocation sequence adequately generated?
Was allocation adequately concealed?
Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?
Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?
Blinding Patients: Was knowledge of the allocated interventions adequately prevented?
Was loss to follow-up (missing outcome data) infrequent?
Are reports of the study free of suggestion of selective outcome reporting?
Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?
Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?
Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?
Oui = 1
Incertain = 0,5
Non pertinent = 0
Non = 0
L'évaluation des critères de rapport permet d'évaluer la transparence avec laquelle les auteurs rapportent les caractéristiques méthodologiques et les caractéristiques de l'essai dans la publication. L'évaluation est divisée en cinq catégories qui sont présentées ci-dessous.
2/4
Randomization
3/4
Outcome Measurements
4/4
Inclusion / Exclusion
2/4
Therapy Description
4/4
Statistics
Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65
L'indice de fragilité est un outil qui aide à l'interprétation des résultats significatifs, en fournissant une mesure de la force d'un résultat. L'indice de fragilité représente le nombre d'événements consécutifs qui doivent être ajoutés à un résultat dichotomique pour que le résultat ne soit plus significatif. Un petit nombre représente un résultat plus faible et un grand nombre un résultat plus fort.
Pourquoi cette étude était-elle nécessaire maintenant ?
Common primary treatment of knee osteoarthritis usually consists of simple analgesics, but when pain can no longer be effectively reduced, a therapy of nonsteroidal anti-inflammatory drugs (NSAIDs) is adopted. Although NSAIDs possess well documented pain relief and anti-inflammatory effects, serious gastrointestinal side-effects have been reported with their use. A preferential alternative to NSAIDs has been intra-articular injections of sodium hyaluronate (Hyalgan), but despite extensive research on a worldwide scale, only one study has been dedicated to investigating the efficacy of such treatment in an Asian population.
Quelle était la principale question de recherche ?
Did 5 weekly intra-articular injections of 20-mg/2mL sodium hyaluronate effectively reduce pain compared to 2mL of placebo saline solution, when measured after 25 weeks from the beginning of therapy?
- Pain (VAS) on the 50 foot walking test was reduced from 45.15mm to 21.53mm (baseline to week 25) in the placebo group and 47.85mm to 17.00mm in the Hyalgan group. The difference in pain at week 25 (P=0.035) and the overall reduction of pain (0.002) were statistically significant, favoring the Hyalgan group.
- Pain and function, as assessed by WOMAC subscales, was significantly reduced with sodium hyaluronate compared to the placebo (P=0.0050 and 0.0038, respectively). Significance was detected by week 5 and carried through for the remainder of the study.
- Although WOMAC stiffness scores were generally more improved in the Hyalgan group, there was no significant difference in this outcome between groups for the duration of the study.
- Both groups achieved slight reduction from baseline 50-foot walking test, with no significant difference.
- No difference was observed in the amount of synovial fluid of the knee between treatment groups.
- Patient and investigator rating of therapy effectiveness did not significantly differ between groups.
- There was no difference in acetaminophen consumption between groups for the duration of the study.
De quoi dois-je me souvenir en priorité ?
The 5-injection administration of 20-mg/mL sodium hyaluronte provided improved pain (100-mm and WOMAC subscale) and function (WOMAC subscale) compared to saline placebo in an Asian population. Difference was detected after 5 weeks and held through to the end of the study at 25 weeks.
Comment cela affectera-t-il les soins prodigués à mes patients ?
The results of this study support the use of sodium hyaluronate for the treatment of knee osteoarthritis in the Asian population. For a more robust understanding of the efficacy of Hyalgan in the Asian population, future studies should consider outcomes in the long-term and employ Minimum Important Differences (MIDs).
AVIS DE NON-RESPONSABILITÉ
Le contenu de cette page est fourni à titre d'information uniquement et n'est pas destiné à remplacer un avis médical, un diagnostic ou un traitement professionnel. Si vous avez besoin d'un traitement médical, demandez toujours l'avis de votre médecin ou rendez-vous au service des urgences le plus proche. Les opinions, croyances et points de vue exprimés par les individus sur le contenu de cette page ne reflètent pas les opinions, croyances et points de vue d'OrthoEvidence.
0 de 4 articles mensuels GRATUITS débloqués
